| Loving Grace Health Care Inc | |
| 111 West Anderson Lane, Ste D204, Austin, Texas 78752 | |
| (512) 673-9362 | |
| Not Available |
| Name | Loving Grace Health Care Inc |
|---|---|
| Location | 111 West Anderson Lane, Ste D204, Austin, Texas |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Home Health Aide |
| Medicare ID | 747947 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 78621, 78660, 78721, 78724, 78727 |
| NPI Number | 1053606301 |
| Organization Name | LOVING GRACE HEALTH CARE, INC |
| Address | 17504 Wiseman Dr, Pflugerville, TX 78660 |
| Phone Number | 512-673-9362 |
News Archive
The Obama administration acknowledged glitches Thursday that will delay online enrollment for small businesses and Spanish-language speakers in the 34 states that elected to not set up their own insurance marketplaces. The postponements amount to a few weeks in the six-month open enrollment period and will not affect the Jan. 1 start date for coverage.
Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has received seed investment funding led by Midven's Rainbow Seed Fund alongside co-investor Cambridge Enterprise, the commercialisation arm of the University of Cambridge, to continue pre-clinical development of their therapy.
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been the most popular treatment for arthritis - despite their association with gastrointestinal (GI) complications, including bleeding ulcers and death.
In new research published in the April 4, 2013 issue of The American Journal of Human Genetics, researchers from Brigham and Women's Hospital demonstrate that some variants in our genes that could put a person at risk for inflammatory diseases such as multiple sclerosis, Crohn's disease or rheumatoid arthritis, have been the target of natural selection over the course of human history.
› Verified 9 days ago
| NPI Number | 1255626370 |
| Organization Name | LOVING GRACE HOME HEALTH CARE INC |
| Address | 1224 Hughmont Dr, 1224 Hughmont Dr, Pflugerville, TX 78660 |
| Phone Number | 512-673-9362 |
News Archive
The Obama administration acknowledged glitches Thursday that will delay online enrollment for small businesses and Spanish-language speakers in the 34 states that elected to not set up their own insurance marketplaces. The postponements amount to a few weeks in the six-month open enrollment period and will not affect the Jan. 1 start date for coverage.
Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has received seed investment funding led by Midven's Rainbow Seed Fund alongside co-investor Cambridge Enterprise, the commercialisation arm of the University of Cambridge, to continue pre-clinical development of their therapy.
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been the most popular treatment for arthritis - despite their association with gastrointestinal (GI) complications, including bleeding ulcers and death.
In new research published in the April 4, 2013 issue of The American Journal of Human Genetics, researchers from Brigham and Women's Hospital demonstrate that some variants in our genes that could put a person at risk for inflammatory diseases such as multiple sclerosis, Crohn's disease or rheumatoid arthritis, have been the target of natural selection over the course of human history.
› Verified 9 days ago
| Quality Rating: | Not Available* |
| * The number of patient episodes for this measure is too small to report. | |
News Archive
The Obama administration acknowledged glitches Thursday that will delay online enrollment for small businesses and Spanish-language speakers in the 34 states that elected to not set up their own insurance marketplaces. The postponements amount to a few weeks in the six-month open enrollment period and will not affect the Jan. 1 start date for coverage.
Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has received seed investment funding led by Midven's Rainbow Seed Fund alongside co-investor Cambridge Enterprise, the commercialisation arm of the University of Cambridge, to continue pre-clinical development of their therapy.
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been the most popular treatment for arthritis - despite their association with gastrointestinal (GI) complications, including bleeding ulcers and death.
In new research published in the April 4, 2013 issue of The American Journal of Human Genetics, researchers from Brigham and Women's Hospital demonstrate that some variants in our genes that could put a person at risk for inflammatory diseases such as multiple sclerosis, Crohn's disease or rheumatoid arthritis, have been the target of natural selection over the course of human history.
› Verified 9 days ago
News Archive
The Obama administration acknowledged glitches Thursday that will delay online enrollment for small businesses and Spanish-language speakers in the 34 states that elected to not set up their own insurance marketplaces. The postponements amount to a few weeks in the six-month open enrollment period and will not affect the Jan. 1 start date for coverage.
Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has received seed investment funding led by Midven's Rainbow Seed Fund alongside co-investor Cambridge Enterprise, the commercialisation arm of the University of Cambridge, to continue pre-clinical development of their therapy.
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been the most popular treatment for arthritis - despite their association with gastrointestinal (GI) complications, including bleeding ulcers and death.
In new research published in the April 4, 2013 issue of The American Journal of Human Genetics, researchers from Brigham and Women's Hospital demonstrate that some variants in our genes that could put a person at risk for inflammatory diseases such as multiple sclerosis, Crohn's disease or rheumatoid arthritis, have been the target of natural selection over the course of human history.
› Verified 9 days ago
Hana Care Texas Location: 223 W Anderson Lane Suite A110, Austin, Texas 78752 Ratings: Phone: (512) 284-7757 | |
Girling Home Health Location: 8701 N Mopac Expressway Suite 165, Austin, Texas 78759 Ratings: Phone: (512) 342-0331 | |
Interim Healthcare Of Austin Location: 505 East Huntland Dr Ste 180, Austin, Texas 78752 Ratings: Phone: (512) 454-5711 | |
Bellcoa Home Health Service Inc Location: 7801 N Lamar Blvd Suite D-79, Austin, Texas 78752 Ratings: Phone: (512) 533-9990 | |
Carter Healthcare Location: 7600 Chevy Chase Drive Bldg 2 Suite 300, Austin, Texas 78752 Ratings: Phone: (830) 625-4837 | |
C C Home Health Central Inc Location: 6633 Hwy 290 East Suite #110, Austin, Texas 78723 Ratings: Phone: (512) 419-7738 |